Nirsevimab immunization to prevent respiratory syncytial virus (RSV) in infants reduced ICU admissions by 97 per cent in two Canadian provinces. Led by the University of Calgary, the Surveillance Program for the Rapid identification and tracking of Infectious Diseases in kids (SPRINT-KIDS) study evaluated the real-world effectiveness of the long-acting monoclonal antibody that gives infants ready-made antibodies to prevent severe illness. The findings are published in JAMA Network Open.

When public health researchers want to know whether diseases such as COVID-19 or polio are circulating in a community, they can look for genetic evidence in wastewater.

Entomologist Dana Price wondered whether the same principle could be applied to mosquitoes. The question led to an unconventional experiment.

“What we did, colloquially, was build a mosquito toilet,” said Price, an associate professor at the Center for Vector Biology, Department of Entomology in the School of Environmental and Biological Sciences and a lead author of a study published in Microbiology Spectrum.

State University of New York (SUNY) Chancellor John B. King Jr. today announced that this technology is a recipient of the latest round of seed funding through the SUNY Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists. This technology from SUNY's University at Albany and Colorado State University allows technicians to simultaneously obtain ECG and EIT data from the same set of electrodes. Simultaneous multiple-current-source EIT uses an independent current source for each electrode, providing better control of the applied current density and increasing sensitivity to small changes, such as those caused by blood movement in the thorax. This sensitive EIT system can produce a regional ventilation-perfusion index for assessing lung health. The simultaneous acquisition of ECG waveforms provides exact cardiac timing that is useful when interpreting the EIT images. Additionally, combining time-aligned multi-electrode ECG waveforms with EIT data can both enhance EIT image reconstructions and enable reconstruction of the heart’s current-density source, providing additional clinical diagnostic capability. The combined EIT/ECG system is a more powerful clinical tool than either modality alone.

State University of New York (SUNY) Chancellor John B. King Jr. today announced that this technology is a recipient of the latest round of seed funding through the SUNY Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists. This technology is a lung-targeting lipid nanoparticle (sLNP) system engineered for the precise delivery of anti-inflammatory agents to lung tissue, to treat acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The sLNPs are constructed from sulfonium lipids, which confer unique properties enabling selective accumulation in the lungs and robust, uniform expression of protein across all lung lobes. This approach sustains therapeutic protein expression directly within lung tissue while minimizing systemic exposure, thereby reducing potential side effects. What differentiates this technology is its lung specificity and the use of sulfonium lipid chemistry, which sets it apart from conventional amine-based lipid nanoparticles commonly used. Traditional LNPs lack organ selectivity, often requiring higher systemic doses that can increase toxicity and limit therapeutic efficacy, especially for lung diseases. In contrast, the sLNP platform enables targeted delivery and sustained local expression of therapeutics, overcoming the pharmacokinetic limitations and short half-life associated with systemic therapies. This targeted approach not only enhances therapeutic outcomes for ALI and ARDS but also opens avenues for treating other pulmonary inflammatory conditions and advancing pulmonary drug delivery. The technology’s novel combination of materials and delivery strategy positions it as a promising solution for unmet clinical needs in respiratory medicine.

State University of New York (SUNY) Chancellor John B. King Jr. today announced that this technology is a recipient of the latest round of seed funding through the SUNY Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists. The inventors have developed a portable handheld spectral reflection (PHASR) scanner that is alignment-free and can acquire three-dimensional spectroscopic images in the terahertz range of 0.1-3 THz. The PHASR scanning device uses an asynchronous optical sampling system to achieve short scan times and is attached only by an umbilical. The device’s portability and quick scan times allow it to be used in clinical settings where previous devices could not be used. The device has been used to characterize burn injuries in animal studies, and a human clinical trial is planned to further test its use for diagnosing burn wounds and predicting wound-healing outcomes.